Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M. Bourcier
A Study of the Safety and Efficacy of Calcipotriol and Betamethasone Dipropionate Scalp Formulation in the Long-Term Management of Scalp Psoriasis
Dermatology
Dermatology
Related publications
Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam for Scalp Psoriasis
Clinical, Cosmetic and Investigational Dermatology
Dermatology
Calcipotriol Plus Betamethasone Versus Betamethasone in Treatment of Scalp Psoriasis in an Iranian Population
Journal of Skin and Stem Cell
New Calcipotriol/Betamethasone Dipropionate Foam Formulation for the Treatment of Psoriasis: An Overview
Revista da Sociedade Portuguesa de Dermatologia e Venereologia
Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel in Japanese Patients With Psoriasis Vulgaris: A Phase III Study
Journal of the Japan Organization of Clinical Dermatologists
Management of Scalp Psoriasis: Current Perspectives
Psoriasis: Targets and Therapy
Dermatology
Rheumatology
Comparison of Efficacy and Safety of Atorvastatin 5% Lotion and Betamethasone 0.1% Lotion in the Treatment of Scalp Seborrheic Dermatitis
Clinical, Cosmetic and Investigational Dermatology
Dermatology
Vasoconstrictor Potencey of Fixed Combination Calcipotriol Plus Betamethasone Dipropionate Foam Versus Other Corticosteroid Psoriasis Treatments
SKIN The Journal of Cutaneous Medicine
Calcipotriol and Betamethasone Dipropionate Exert Additive Inhibitory Effects on the Cytokine Expression of Inflammatory Dendritic Cell–Th17 Cell Axis in Psoriasis
Journal of Dermatological Science
Dermatology
Biochemistry
Molecular Biology
1% Pimecrolimus, 0.005% Calcipotriol, and 0.1% Betamethasone in the Treatment of Intertriginous Psoriasis
Archives of Dermatology
